COVID-19 is a disease caused by the novel coronavirus now known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).The first human cases were reported at Wuhan, China, in December of 2019 and subsequently spread to nearly every country leading the World Health Organization (WHO) to declare the outbreak as a pandemic or a Public Health Emergency of International Concern (WHO, 2020). The COVID-19 pandemic poses a significant challenge to healthcare professionals and health systems around the world, most notably the disruption of service delivery. Genetic counselors (GCs), as part of the healthcare team, play an important role in providing genetic services by helping patients and/or families "understand and adapt to the medical, psychological, and familial implications of genetic contributions to disease", (Resta et al., 2006). Genetics and genetic counseling have become integral to health care as we learn more about genetic risks for disease (Bruder, 2020). The typical work setting for most GCs is in a clinic or hospital. However, during the COVID-19 pandemic, to help prevent the further spread of the virus, clinics and hospitals have restricted in-person delivery of healthcare services that are not deemed urgent, including genetic counseling. Patients' access to genetic counseling services has thus been limited, which prompted GCs to utilize an alternative way to provide counseling through telegenetics. An article from Pagliazzi et al. (2020) described their genetic counseling experience in Tuscany, Italy, when the pandemic hit. It was widely known that Italy was one of the hardest-hit countries during the pandemic. A pediatric tertiary hospital in Tuscany stratified their scheduled visits and assessed which cases would be seen via faceto-face and which would be seen via telemedicine. All prenatal visits were face to face since the patient still had to go the hospital for